Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

[Supply disruptions and drug shortages: the example of benzathine benzylpenicillin].

Dhanani A, Parent du Chatelet I, Ioughlissen S, Maison P.

Rev Prat. 2018 Oct;68(8):849-854. French.

PMID:
30869447
2.

Community outbreak of serogroup B invasive meningococcal disease in Beaujolais, France, February to June 2016: from alert to targeted vaccination.

Thabuis A, Tararbit K, Taha MK, Dejour-Salamanca D, Ronin V, Parent du Chatelet I, Spaccaferri G.

Euro Surveill. 2018 Jul;23(28). doi: 10.2807/1560-7917.ES.2018.23.28.1700590.

3.

Clonal replacement and expansion among invasive meningococcal isolates of serogroup W in France.

Hong E, Barret AS, Terrade A, Denizon M, Antona D, Aouiti-Trabelsi M, Deghmane AE, Parent du Châtelet I, Levy-Bruhl D, Taha MK.

J Infect. 2018 Feb;76(2):149-158. doi: 10.1016/j.jinf.2017.10.015. Epub 2017 Nov 10.

4.

Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006-2015.

Parent du Chatelet I, Deghmane AE, Antona D, Hong E, Fonteneau L, Taha MK, Lévy-Bruhl D.

J Infect. 2017 Jun;74(6):564-574. doi: 10.1016/j.jinf.2017.02.011. Epub 2017 Mar 7.

PMID:
28279715
5.

Socioeconomic inequalities to accessing vaccination against human papillomavirus in France: Results of the Health, Health Care and Insurance Survey, 2012.

Guthmann JP, Pelat C, Célant N, Parent du Chatelet I, Duport N, Rochereau T, Lévy-Bruhl D.

Rev Epidemiol Sante Publique. 2017 Apr;65(2):109-117. doi: 10.1016/j.respe.2017.01.100. Epub 2017 Feb 24.

PMID:
28238476
6.

Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.

Heard I, Tondeur L, Arowas L, Demazoin M, Falguières M, Parent Du Chatelet I; pour le groupe CHlaHPV.

J Infect Dis. 2017 Mar 1;215(5):757-763. doi: 10.1093/infdis/jiw639.

PMID:
28011911
7.

Evolutionary Events Associated with an Outbreak of Meningococcal Disease in Men Who Have Sex with Men.

Taha MK, Claus H, Lappann M, Veyrier FJ, Otto A, Becher D, Deghmane AE, Frosch M, Hellenbrand W, Hong E, Parent du Châtelet I, Prior K, Harmsen D, Vogel U.

PLoS One. 2016 May 11;11(5):e0154047. doi: 10.1371/journal.pone.0154047. eCollection 2016.

8.

Epidemiological impact and cost-effectiveness of introducing vaccination against serogroup B meningococcal disease in France.

Lecocq H, Parent du Châtelet I, Taha MK, Lévy-Bruhl D, Dervaux B.

Vaccine. 2016 Apr 27;34(19):2240-50. doi: 10.1016/j.vaccine.2016.03.020. Epub 2016 Mar 19.

PMID:
27002504
9.

The use of reimbursement data for timely monitoring of vaccination coverage: the example of human papillomavirus vaccine following public concerns about vaccine safety.

Fonteneau L, Ragot M, Parent du Châtelet I, Guthmann JP, Lévy-Bruhl D.

BMC Public Health. 2015 Dec 12;15:1233. doi: 10.1186/s12889-015-2575-7.

10.

Serogroup C invasive meningococcal disease among men who have sex with men and in gay-oriented social venues in the Paris region: July 2013 to December 2014.

Aubert L, Taha M, Boo N, Le Strat Y, Deghmane AE, Sanna A, Barret AS, Lévy-Bruhl D, Vandentorren S, Parent du Châtelet I.

Euro Surveill. 2015 Jan 22;20(3). pii: 21016. No abstract available.

11.

[Recent cases of maternal and fetal rubella].

Delisle E, Parent du Châtelet I, Vauloup-Fellous C, Rousseau C.

Med Mal Infect. 2014 Aug;44(8):390-2. doi: 10.1016/j.medmal.2014.07.004. Epub 2014 Aug 22. French. No abstract available.

PMID:
25156677
12.

Measles elimination efforts and 2008-2011 outbreak, France.

Antona D, Lévy-Bruhl D, Baudon C, Freymuth F, Lamy M, Maine C, Floret D, Parent du Chatelet I.

Emerg Infect Dis. 2013 Mar;19(3):357-64. doi: 10.3201/eid1903.121360.

13.

[Measles in France].

Antona D, Baudon C, Freymuth F, Lamy M, Maine C, Parent du Chatelet I, Lévy-Bruhl D.

Med Sci (Paris). 2012 Nov;28(11):1003-7. doi: 10.1051/medsci/20122811023. Epub 2012 Nov 12. French.

14.

A cluster of meningococcal disease caused by rifampicin-resistant C meningococci in France, April 2012.

Mounchetrou Njoya I, Deghmane A, Taha M, Isnard H, Parent du Chatelet I.

Euro Surveill. 2012 Aug 23;17(34). pii: 20254.

15.

W135 invasive meningococcal infections imported from Sub-Saharan Africa to France, January to April 2012.

Parent du Chatelet I, Barboza P, Taha MK.

Euro Surveill. 2012 May 24;17(21). pii: 20181.

16.

Community outbreak of group B meningococcal disease in southwest France--December 2008 to September 2009.

Delisle E, Larrieu S, Simões J, Laylle N, De Pommerol M, Taha MK, Termignon JL, Parent du Châtelet I.

Euro Surveill. 2010 Sep 16;15(37). pii: 19665.

17.

Spotlight on measles 2010: update on the ongoing measles outbreak in France, 2008-2010.

Parent du Châtelet I, Antona D, Freymuth F, Muscat M, Halftermeyer-Zhou F, Maine C, Floret D, Lévy-Bruhl D.

Euro Surveill. 2010 Sep 9;15(36). pii: 19656.

18.

Emergence of new virulent Neisseria meningitidis serogroup C sequence type 11 isolates in France.

Deghmane AE, Parent du Chatelet I, Szatanik M, Hong E, Ruckly C, Giorgini D, Lévy-Bruhl D, Alonso JM, Taha MK.

J Infect Dis. 2010 Jul 15;202(2):247-50. doi: 10.1086/653583.

PMID:
20515410
19.

Phylogenetic analysis of rubella viruses involved in congenital rubella infections in France between 1995 and 2009.

Vauloup-Fellous C, Hübschen JM, Abernathy ES, Icenogle J, Gaidot N, Dubreuil P, Parent-du-Châtelet I, Grangeot-Keros L, Muller CP.

J Clin Microbiol. 2010 Jul;48(7):2530-5. doi: 10.1128/JCM.00181-10. Epub 2010 May 12.

20.

Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital.

Vauloup-Fellous C, Picone O, Cordier AG, Parent-du-Châtelet I, Senat MV, Frydman R, Grangeot-Keros L.

J Clin Virol. 2009 Dec;46 Suppl 4:S49-53. doi: 10.1016/j.jcv.2009.09.003. Epub 2009 Oct 6.

PMID:
19811947
21.

A 2-year study on cytomegalovirus infection during pregnancy in a French hospital.

Picone O, Vauloup-Fellous C, Cordier AG, Parent Du Châtelet I, Senat MV, Frydman R, Grangeot-Keros L.

BJOG. 2009 May;116(6):818-23. doi: 10.1111/j.1471-0528.2009.02139.x.

22.

Measles resurgence in France in 2008, a preliminary report.

Parent du Châtelet I, Floret D, Antona D, Lévy-Bruhl D.

Euro Surveill. 2009 Feb 12;14(6). pii: 19118.

23.

Outbreak of measles in two private religious schools in Bourgogne and Nord-Pas-de-Calais regions of France, May-July 2008 (preliminary results).

Noury U, Stoll J, Haeghebaert S, Antona D, Parent du Châtelet I; investigation team.

Euro Surveill. 2008 Aug 28;13(35). pii: 18961. No abstract available.

24.

An outbreak of measles in Reims, eastern France, January-March 2008--a preliminary report.

Thierry S, Alsibai S, Parent du Chatelet I; investigation team.

Euro Surveill. 2008 Mar 27;13(13). pii: 8078. No abstract available.

25.

[Increased incidence of invasive meningococcal disease in Seine-Maritime. The evolving epidemiology due to the B:14:P1.7,16 strain].

Parent du Châtelet I, Taha MK, Sesboüé C, Rouaud P, Perrocheau A, Lévy-Bruhl D.

Arch Pediatr. 2007 Jun;14(6):537-40. Epub 2007 Apr 5. French. No abstract available.

PMID:
17418547
26.

Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005.

Rouaud P, Perrocheau A, Taha MK, Sesboué C, Forgues AM, Parent du Châtelet I, Levy-Bruhl D.

Euro Surveill. 2006 Jul;11(7):178-81.

PMID:
16966800
27.

The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.

Traoré Y, Njanpop-Lafourcade BM, Adjogble KL, Lourd M, Yaro S, Nacro B, Drabo A, Parent du Châtelet I, Mueller JE, Taha MK, Borrow R, Nicolas P, Alonso JM, Gessner BD.

Clin Infect Dis. 2006 Oct 1;43(7):817-22. Epub 2006 Aug 22.

PMID:
16941360
28.

Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso.

Yaro S, Lourd M, Traoré Y, Njanpop-Lafourcade BM, Sawadogo A, Sangare L, Hien A, Ouedraogo MS, Sanou O, Parent du Châtelet I, Koeck JL, Gessner BD.

Clin Infect Dis. 2006 Sep 15;43(6):693-700. Epub 2006 Aug 15.

PMID:
16912941
29.

Prolonged outbreak of B meningococcal disease in the Seine-Maritime department, France, January 2003 to June 2005.

Rouaud P, Perrocheau A, Taha MK, Sesboué C, Forgues AM, Parent du Châtelet I, Lévy-Bruhl D.

Euro Surveill. 2006 Jul;11(7):3-4. doi: 10.2807/esm.11.07.00635-en.

PMID:
29208111
30.

The epidemiology of Haemophilus influenzae type b meningitis in Burkina Faso.

Yaro S, Lourd M, Naccro B, Njanpop-Lafourcade BM, Hien A, Ouedraogo MS, Traore Y, Schouls LM, Parent du Châtelet I, Gessner BD; Clinical Group; Laboratory Group.

Pediatr Infect Dis J. 2006 May;25(5):415-9.

PMID:
16645505
31.

Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135.

Djibo S, Njanpop Lafourcade BM, Boisier P, Moussa A, Kobo G, Sidikou F, Hien A, Bieboure G, Aguilera JF, Parent du Chatelet I, Gessner BD, Chanteau S.

Trans R Soc Trop Med Hyg. 2006 Jun;100(6):573-8. Epub 2006 Jan 10.

PMID:
16406096
32.

The establishment of Neisseria meningitidis serogroup W135 of the clonal complex ET-37/ST-11 as an epidemic clone and the persistence of serogroup A isolates in Burkina Faso.

Njanpop-Lafourcade BM, Parent du Châtelet I, Sanou O, Alonso JM, Taha MK.

Microbes Infect. 2005 Apr;7(4):645-9. Epub 2005 Mar 17.

PMID:
15823512
33.

Measles outbreak in the Provence-Alpes-Côte d'Azur region, France, January-July 2003.

Six C, Franke F, Mantey K, Zandotti C, Freymuth F, Wild F, Parent du Châtelet I, Malfait P.

Euro Surveill. 2005 Jan;10(1):46-8.

PMID:
15701935
34.

Measles outbreak in the Provence - Alpes - Côte d'Azur region, France, January - July 2003.

Six C, Franke F, Mantey K, Zandotti C, Freymuth F, Wild F, Parent du Châtelet I, Malfait P.

Euro Surveill. 2005 Jan;10(1):11-12. doi: 10.2807/esm.10.01.00515-en.

PMID:
29183482
35.

Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.

Parent du Châtelet I, Traore Y, Gessner BD, Antignac A, Naccro B, Njanpop-Lafourcade BM, Ouedraogo MS, Tiendrebeogo SR, Varon E, Taha MK.

Clin Infect Dis. 2005 Jan 1;40(1):17-25. Epub 2004 Dec 8.

PMID:
15614687
36.

[Assessment of the diagnostic value of RT-PCR on amniotic fluid for prenatal diagnosis of congenital rubella infection].

Macé M, Cointe D, Six C, Levy-Bruhl D, Parent du Chatelet I, Ingrand D, Grangeot-Keros L.

Pathol Biol (Paris). 2004 Nov;52(9):540-3. French.

PMID:
15531119
37.

Diagnostic value of reverse transcription-PCR of amniotic fluid for prenatal diagnosis of congenital rubella infection in pregnant women with confirmed primary rubella infection.

Macé M, Cointe D, Six C, Levy-Bruhl D, Parent du Châtelet I, Ingrand D, Grangeot-Keros L.

J Clin Microbiol. 2004 Oct;42(10):4818-20.

38.

Rubella control in France.

Lévy-Bruhl D, Six C, Parent du Châtelet I.

Euro Surveill. 2004 Apr;9(4):13-14. doi: 10.2807/esm.09.04.00460-en.

PMID:
29183461
39.

[Microeconomic evaluation of a mass preventive immunisation campaign against meningococcal meningitis and yellow fever in Senegal in 1997].

da Silva A, Parent du Châtelet I, Beckr Gaye A, Dompnier JP, Seck I.

Sante. 2003 Oct-Dec;13(4):215-23. French.

40.

Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules.

Parent du Châtelet I, Merchant AT, Fisher-Hoch S, Luby SP, Plotkin SA, Moatter T, Agboatwalla M, McCormick JB.

Vaccine. 2003 Apr 2;21(15):1710-8.

PMID:
12639494
41.

Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger.

Taha MK, Parent Du Chatelet I, Schlumberger M, Sanou I, Djibo S, de Chabalier F, Alonso JM.

J Clin Microbiol. 2002 Mar;40(3):1083-4.

42.
43.
44.

[Epidemiological study of noted children under 6 years of age in danger in medicosocial services in a French department (Ille et Vilaine)].

Parent du Chatelet I, Roussey M, Morellec J, Chaperon J.

Pediatrie. 1993;48(3):195-203. French.

PMID:
8393975
45.

A French version of the Sickness Impact Profile (SIP): stages in the cross cultural validation of a generic quality of life scale.

Chwalow AJ, Lurie A, Bean K, Parent du Chatelet I, Venot A, Dusser D, Douot Y, Strauch G.

Fundam Clin Pharmacol. 1992;6(7):319-26.

PMID:
1490652

Supplemental Content

Loading ...
Support Center